Global support for a quality solution

We lead innovation in peptide API’s to the benefit of millions of patients

Contact us

Market leader in peptide API manufacturing and services

PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API). 

Ad hoc announcements pursuant to Art. 53 LR

Transformational progress taking shape, profitability impacted by rapid expansion – appointment of Marc Augustin as new CFO

15 Aug 2023 - Baar, 15 August 2023 – PolyPeptide today announced its results for H1 2023, updated guidance for 2023 and the appointment of its new CFO: Reported results […]

Read more
Ad hoc announcements pursuant to Art. 53 LR

PolyPeptide delivers revenue of around EUR 132 million for H1 – expects net loss for H1 and full year 2023

13 Jul 2023 - Baar, July 13th, 2023 – PolyPeptide Group AG (SIX: PPGN) achieves H1 2023 revenue of around EUR 132 million driven by strong momentum in its peptide […]

Read more

PolyPeptide video

PolyPeptide Group - Ahead on green peptide chemistry